• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷公藤红素诱导乳腺癌细胞中mTOR的泛素依赖性降解。

Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells.

作者信息

Li Xiaoli, Zhu Guangbei, Yao Xintong, Wang Ning, Hu Ronghui, Kong Qingxin, Zhou Duanfang, Long Liangyuan, Cai Jiali, Zhou Weiying

机构信息

Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing 400016, P.R. China,

Chongqing Key Laboratory of Drug Metabolism, Chongqing 400016, P.R. China,

出版信息

Onco Targets Ther. 2018 Dec 11;11:8977-8985. doi: 10.2147/OTT.S187315. eCollection 2018.

DOI:10.2147/OTT.S187315
PMID:30588010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6294079/
Abstract

BACKGROUND

Celastrol is a major active component of the thunder god vine () used in traditional Chinese medicine to treat chronic inflammatory and autoimmune diseases. Celastrol inhibits PI3K-Akt-mTOR signaling, which is frequently dysregulated in tumors and critical for tumor-cell proliferation and survival, but the underlying mechanisms are still not fully understood. In the present study, we investigated detailed mechanisms of celastrol inhibition of mTOR signaling in breast cancer cells.

METHODS

First, we evaluated the effect of celastrol on breast cancer-cell growth using MTT assays. Second, we examined the effects of celastrol on mTOR phosphorylation and expression using Western blot. Furthermore, we investigated the cause of mTOR downregulation by celastrol using immunoprecipitation assays. In addition, we evaluated the effect of celastrol on an MDA-MB231 cell-derived xenograft model.

RESULTS

Celastrol suppressed breast cancer cell growth in vitro and in vivo. Celastrol inhibited mTOR phosphorylation and induced mTOR ubiquitination, resulting in its proteasomal degradation. Mechanistically, we found that mTOR is a client of Hsp90-Cdc37 chaperone complex, and celastrol disrupts mTOR interaction with chaperone Hsp90 while promoting mTOR association with cochaperone Cdc37.

CONCLUSION

Our study reveals that celastrol suppresses mTOR signaling, at least in part through regulating its association with chaperones and inducing its ubiquitination.

摘要

背景

雷公藤红素是中药雷公藤用于治疗慢性炎症和自身免疫性疾病的主要活性成分。雷公藤红素抑制PI3K-Akt-mTOR信号传导,该信号传导在肿瘤中经常失调,对肿瘤细胞的增殖和存活至关重要,但其潜在机制仍未完全了解。在本研究中,我们研究了雷公藤红素抑制乳腺癌细胞中mTOR信号传导的详细机制。

方法

首先,我们使用MTT试验评估雷公藤红素对乳腺癌细胞生长的影响。其次,我们使用蛋白质免疫印迹法检测雷公藤红素对mTOR磷酸化和表达的影响。此外,我们使用免疫沉淀试验研究雷公藤红素下调mTOR的原因。另外,我们评估了雷公藤红素对MDA-MB231细胞来源的异种移植模型的影响。

结果

雷公藤红素在体外和体内均抑制乳腺癌细胞生长。雷公藤红素抑制mTOR磷酸化并诱导mTOR泛素化,导致其蛋白酶体降解。从机制上讲,我们发现mTOR是Hsp90-Cdc37伴侣复合物的底物,雷公藤红素破坏mTOR与伴侣蛋白Hsp90的相互作用,同时促进mTOR与辅助伴侣蛋白Cdc37的结合。

结论

我们的研究表明,雷公藤红素至少部分通过调节其与伴侣蛋白的结合并诱导其泛素化来抑制mTOR信号传导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/6172e3a57d80/ott-11-8977Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/7c4d8cef25ba/ott-11-8977Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/60a8114adc2a/ott-11-8977Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/ff36e3ac6252/ott-11-8977Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/6172e3a57d80/ott-11-8977Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/7c4d8cef25ba/ott-11-8977Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/60a8114adc2a/ott-11-8977Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/ff36e3ac6252/ott-11-8977Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa8f/6294079/6172e3a57d80/ott-11-8977Fig4.jpg

相似文献

1
Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells.雷公藤红素诱导乳腺癌细胞中mTOR的泛素依赖性降解。
Onco Targets Ther. 2018 Dec 11;11:8977-8985. doi: 10.2147/OTT.S187315. eCollection 2018.
2
Celastrol inhibits mouse B16-F10 melanoma cell survival by regulating the PI3K/AKT/mTOR signaling pathway and repressing HIF-1α expression.雷公藤红素通过调节PI3K/AKT/mTOR信号通路并抑制HIF-1α表达来抑制小鼠B16-F10黑色素瘤细胞的存活。
Discov Oncol. 2024 May 21;15(1):178. doi: 10.1007/s12672-024-01045-6.
3
Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.雷公藤红素是从中国“雷公藤”中提取的一种三萜类化合物,是一种有效的蛋白酶体抑制剂,可抑制裸鼠体内人前列腺癌的生长。
Cancer Res. 2006 May 1;66(9):4758-65. doi: 10.1158/0008-5472.CAN-05-4529.
4
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells.一种新型热休克蛋白90(Hsp90)抑制剂,可破坏Hsp90/细胞周期蛋白依赖性激酶37(Cdc37)复合物以对抗胰腺癌细胞。
Mol Cancer Ther. 2008 Jan;7(1):162-70. doi: 10.1158/1535-7163.MCT-07-0484.
5
Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.雷公藤两种主要化合物雷公藤内酯醇和雷公藤红素的协同抗癌作用
Oncotarget. 2015 Oct 20;6(32):32790-804. doi: 10.18632/oncotarget.5411.
6
Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells.雷公藤红素靶向作用于线粒体呼吸链复合物 I,诱导肿瘤细胞内活性氧依赖的细胞毒性。
BMC Cancer. 2011 May 14;11:170. doi: 10.1186/1471-2407-11-170.
7
Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37.人类热休克蛋白90(HSP90)中的Y493G和K546D突变破坏了雷公藤红素的结合,并减少了与细胞周期蛋白依赖性激酶37(Cdc37)的相互作用。
FEBS Open Bio. 2016 May 25;6(7):729-34. doi: 10.1002/2211-5463.12081. eCollection 2016 Jul.
8
Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.雷公藤红素通过启动ROS/Akt/p70S6K信号通路并增强缺氧诱导因子-1α蛋白合成来刺激肿瘤细胞中的缺氧诱导因子-1活性。
PLoS One. 2014 Nov 10;9(11):e112470. doi: 10.1371/journal.pone.0112470. eCollection 2014.
9
Celastrol: Molecular targets of Thunder God Vine.雷公藤红素:雷公藤的分子靶点。
Biochem Biophys Res Commun. 2010 Apr 9;394(3):439-42. doi: 10.1016/j.bbrc.2010.03.050. Epub 2010 Mar 10.
10
Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study.雷公藤红素对人胶质瘤生长的抗血管生成作用:一项体外和体内研究。
Chin Med J (Engl). 2009 Jul 20;122(14):1666-73.

引用本文的文献

1
Mechanistic study of celastrol-mediated inhibition of proinflammatory activation of macrophages in IgA nephropathy via down-regulating ECM1.通过下调 ECM1,研究塞拉托醇抑制 IgA 肾病中巨噬细胞促炎激活的机制。
Int J Biol Sci. 2024 Oct 21;20(14):5731-5746. doi: 10.7150/ijbs.99738. eCollection 2024.
2
The effect of celastrol in combination with 5-fluorouracil on proliferation and apoptosis of gastric cancer cell lines.雷公藤红素联合氟尿嘧啶对胃癌细胞系增殖和凋亡的影响。
Oncol Res. 2024 Jun 20;32(7):1231-1237. doi: 10.32604/or.2024.047187. eCollection 2024.
3
Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach.探讨丁酸钠与雷公藤红素联合应用于脑胶质瘤细胞系的抗癌作用:一种新的治疗方法。
Med Oncol. 2024 Mar 26;41(5):97. doi: 10.1007/s12032-024-02340-6.
4
Ultrasound-mediated multifunctional magnetic microbubbles for drug delivery of celastrol in VX2 liver transplant tumors.超声介导多功能磁性微泡用于鬼臼毒素在 VX2 肝移植瘤中的药物递送。
Drug Deliv Transl Res. 2024 Feb;14(2):555-570. doi: 10.1007/s13346-023-01421-9. Epub 2023 Aug 28.
5
Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα and .雷公藤红素调节肠道微生物群和胆汁酸代谢,通过调节法尼醇X受体(FXR)和视黄酸X受体α(RXRα)之间的相互作用来减轻肝细胞癌的增殖。
Front Pharmacol. 2023 Feb 15;14:1124240. doi: 10.3389/fphar.2023.1124240. eCollection 2023.
6
Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations.雷公藤红素对鼻咽癌蛋白质靶点的作用探索:网络药理学、分子对接及实验评估
Front Pharmacol. 2022 Nov 23;13:996728. doi: 10.3389/fphar.2022.996728. eCollection 2022.
7
Endoplasmic reticulum stress inhibits AR expression via the PERK/eIF2α/ATF4 pathway in luminal androgen receptor triple-negative breast cancer and prostate cancer.内质网应激通过PERK/eIF2α/ATF4途径抑制腔面雄激素受体三阴性乳腺癌和前列腺癌中的AR表达。
NPJ Breast Cancer. 2022 Jan 10;8(1):2. doi: 10.1038/s41523-021-00370-1.
8
Screening of a Focused Ubiquitin-Proteasome Pathway Inhibitor Library Identifies Small Molecules as Novel Modulators of Botulinum Neurotoxin Type A Toxicity.对聚焦泛素-蛋白酶体途径抑制剂文库的筛选鉴定出小分子作为新型A型肉毒杆菌神经毒素毒性调节剂。
Front Pharmacol. 2021 Sep 27;12:763950. doi: 10.3389/fphar.2021.763950. eCollection 2021.
9
Qihu Preparation Ameliorates Diabetes by Activating the AMPK Signaling Pathway in db/db Mice.芪虎制剂通过激活db/db小鼠的AMPK信号通路改善糖尿病。
Diabetes Metab Syndr Obes. 2021 Jul 14;14:3229-3241. doi: 10.2147/DMSO.S312137. eCollection 2021.
10
Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications.基于纳米技术的雷公藤红素制剂及其治疗应用。
Front Pharmacol. 2021 Jun 11;12:673209. doi: 10.3389/fphar.2021.673209. eCollection 2021.

本文引用的文献

1
Molecular targets of celastrol in cancer: Recent trends and advancements.雷公藤红素在癌症中的分子靶点:最新趋势和进展。
Crit Rev Oncol Hematol. 2018 Aug;128:70-81. doi: 10.1016/j.critrevonc.2018.05.019. Epub 2018 Jun 5.
2
How Hsp90 and Cdc37 Lubricate Kinase Molecular Switches.热休克蛋白90(Hsp90)和细胞分裂周期蛋白37(Cdc37)如何调控激酶分子开关。
Trends Biochem Sci. 2017 Oct;42(10):799-811. doi: 10.1016/j.tibs.2017.07.002. Epub 2017 Aug 4.
3
Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer.雄激素受体拮抗剂与mTOR和HER2抑制在乳腺癌中的协同作用。
Mol Cancer Ther. 2017 Jul;16(7):1389-1400. doi: 10.1158/1535-7163.MCT-17-0111. Epub 2017 May 3.
4
The HSP90 chaperone machinery.HSP90 伴侣分子机器。
Nat Rev Mol Cell Biol. 2017 Jun;18(6):345-360. doi: 10.1038/nrm.2017.20. Epub 2017 Apr 21.
5
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab.针对间充质三阴性乳腺癌的 PI3K/AKT/mTOR 通路治疗:mTOR 抑制联合脂质体多柔比星和贝伐珠单抗的 1 期试验证据。
JAMA Oncol. 2017 Apr 1;3(4):509-515. doi: 10.1001/jamaoncol.2016.5281.
6
mTORC1 and mTORC2 in cancer and the tumor microenvironment.癌症及肿瘤微环境中的mTORC1和mTORC2
Oncogene. 2017 Apr 20;36(16):2191-2201. doi: 10.1038/onc.2016.363. Epub 2016 Oct 17.
7
Emerging role of mTOR in the response to cancer therapeutics.mTOR在癌症治疗反应中的新作用。
Trends Cancer. 2016 May;2(5):241-251. doi: 10.1016/j.trecan.2016.03.008.
8
mTOR inhibitors in cancer therapy.癌症治疗中的mTOR抑制剂
F1000Res. 2016 Aug 25;5. doi: 10.12688/f1000research.9207.1. eCollection 2016.
9
Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase.Hsp90-Cdc37-Cdk4 的原子结构揭示了 Hsp90 捕获并稳定未折叠激酶。
Science. 2016 Jun 24;352(6293):1542-7. doi: 10.1126/science.aaf5023.
10
Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.热休克蛋白90激酶组特异性伴侣蛋白Cdc37对蛋白激酶的识别与分选的分子机制
Mol Cell. 2016 Apr 21;62(2):260-271. doi: 10.1016/j.molcel.2016.04.005.